Ana T. Amaral
Sevilla, AN 41009, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Hippo signalling pathway mediates oncogenic properties of NAB2::STAT6 in solitary fibrous tumour.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 01, 2025
Hippo signalling pathway mediates oncogenic properties of NAB2::STAT6 in solitary fibrous tumour.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 01, 2025
Next generation CAR-T cells to tackle solid tumors.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 25, 2025
Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcoma.
Journal: Molecular oncology
Published: February 28, 2025
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry.
Journal: Cell death & disease
Published: September 15, 2022
Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell-Matrix Interactions.
Journal: International journal of molecular sciences
Published: May 19, 2022
Endoglin in the Spotlight to Treat Cancer.
Journal: International journal of molecular sciences
Published: January 22, 2021
Selective modulation by PARP-1 of HIF-1α-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions.
Journal: Redox biology
Published: December 23, 2020
Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape.
Journal: Cells
Published: February 27, 2020
Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
Journal: The Journal of pathology
Published: July 16, 2019
Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 26, 2018
Last Updated: 09/26/2026